FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

765663002: Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3674142015 Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3674143013 Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has manufactured dose form Prolonged-release oral tablet true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Product containing bumetanide in oral dose form (medicinal product form) false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value un false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Potassium chloride-containing product in oral dose form false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength denominator value un false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 500 false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Bumetanide (substance) false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Bumetanide (substance) false Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Potassium chloride false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Has presentation strength numerator value 573 false Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Count of base of active ingredient deux false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a Bumetanide and potassium chloride only product in oral dose form true Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Plays role Loop diuretic therapeutic role false Inferred relationship Some
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Bumetanide (substance) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Bumetanide (substance) true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Potassium chloride true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mcg true Inferred relationship Some 1
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet This attribute specifies the numerator unit for the presentation strength of a product. mg true Inferred relationship Some 2
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Potassium chloride true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start